F2-Isoprostanes Are Associated With Increased Fracture Risk in Type 2 Diabetes - Summary - MDSpire

F2-Isoprostanes Are Associated With Increased Fracture Risk in Type 2 Diabetes

  • By

  • Bowen Wang

  • Ruban Dhaliwal

  • Susan K Ewing

  • Ann V Schwartz

  • Deepak Vashishth

  • November 8, 2024

  • 0 min

Share

Objective:

To investigate the association between plasma F2-isoprostanes levels and incident clinical fracture risk in older adults with type 2 diabetes (T2D).

Key Findings:
  • Each SD increase in log plasma F2-isoprostanes was associated with a 93% increase in fracture risk in the T2D group (HR = 1.93, P = .002).
  • No significant association was found in the nondiabetes group (HR = 0.98, P = .79).
  • Log plasma F2-isoprostanes correlated with declines in total hip BMD in the T2D group (r = -0.25, P = .003).
Interpretation:

Elevated plasma F2-isoprostanes levels are linked to increased fracture risk in older adults with T2D, suggesting oxidative stress may contribute to bone fragility beyond BMD measurements.

Limitations:
  • The study is observational, limiting causal inferences.
  • The cohort may not be representative of all older adults with T2D.
Conclusion:

Plasma F2-isoprostanes may serve as a potential biomarker for assessing fracture risk in individuals with T2D, highlighting the need for further research into oxidative stress and bone health.

Original Source(s)

F2-Isoprostanes Are Associated With Increased Fracture Risk in Type 2 Diabetes

  • by Bowen Wang, Ruban Dhaliwal, Susan K Ewing, Ann V Schwartz, Deepak Vashishth

  • November 8, 2024

Related Content

AI Boosts Diabetic Eye Care Access

Recent study highlights how integrated AI-assisted DR screening in primary care clinics can improve access and decrease disparity

  • May 5, 2026

  • 3 min
Diabetes Mellitus Coding in Retina

Age-related macular degeneration (AMD) is among the most common retinal diagnoses. Although the clinical features of the disease are well known, ICD-10 coding can be confusing if details such as stage, activity, and laterality are not clearly documented. Incomplete documentation may prompt questions about the medical necessity of diagnostic tests or intravitreal injections. This Q&A addresses common sources of confusion and offers practical guidance to support clear, accurate documentation.

A Nomogram for Predicting Low Bone Mineral Density in the Elderly Using Chest CT